CA-125 in gynecological malignancies
- 1 June 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (6) , 713-717
- https://doi.org/10.1016/0277-5379(87)90267-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- CA 12–5 serum levels and histological findings at second look in patients with ovarian cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Longitudinal study of CEA and CA125 in ovarian cancerGynecologic Oncology, 1985
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Erfahrungen mit CA 125, einem Tumormarker für maligne epitheliale Ovarialtumoren*Geburtshilfe und Frauenheilkunde, 1985
- Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenAmerican Journal of Obstetrics and Gynecology, 1984
- Detection of Malignant Ovarian NeoplasmsObstetrical & Gynecological Survey, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Carcinoembryonic antigen in patients with gynecologic malignanciesAmerican Journal of Obstetrics and Gynecology, 1975